Treatment of impetigo and antimicrobial resistance
A recent review in Journal of Drugs in Dermatology reviewed the information provided to physicians and stakeholders regarding antimicrobial resistance (AMR) in the treatment of impetigo.
Impetigo is a contagious bacterial infection that affects the superficial layers of the skin, and topical agents prescribed for the condition are seeing an increase in AMR worldwide, causing treatment to fail. In response, the World Health Organization (WHO) developed a comprehensive action plan on AMR but omitted information on the AMR management program for topical antibiotics.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.